Asthma

Atrial Fibrillation

Autoimmune Diseases

Biologics

Biosimilars

Blood Cancer

Breast Cancer

COVID-19

Cardiovascular Diseases

Depression

Dermatology

Diabetes

Digital Health

Drug Coverage

Duchenne Muscular Dystrophy

Eyecare

Friedreich Ataxia

Gene Therapy

Graft Versus Host Disease

Heart Failure

Hemophilia

Hypertrophic Cardiomyopathy (HCM)

Infectious Disease

Leukemia and Lymphoma

Liver Disease

Lung Cancer

Mental Health

Multiple Sclerosis

NSCLC

Neonatal Care

Nephrology

Obstetrics-Gynecology & Women's Health

Oncology

Opioids

PTSD

Pain

Pediatrics

Plaque Psoriasis

Population Health

Post-Acute Care

Prescription Digital Therapeutics

Pulmonary Arterial Hypertension

Reproductive Health

Respiratory Conditions

Safety & Recalls

Schizophrenia

Skin Cancer

Sleep Disorders

Solid Tumors

Spinal Muscular Atrophy

Substance Use Disorder

The Improving Patient Access Podcast

Type I Diabetes

Type II Inflammation

Ulcerative Colitis

Urology

Urothelial Carcinoma

Vaccines

Women's Health

News

Media

Between the Lines

Expert Interviews

K-Cast

Medical World News

Podcasts

Population Health Perspectives

Conferences

Partners

Publications

All Publications

MHE Publication

Formulary Watch Supplements

Formulary Watch Spotlights

Supplements And Featured Publications

Events

Webinars

CME/CE

Resources

PBMI Innovators

Emerging Leaders

Interactive Tools

PBM Directory

Subscribe

Articles

COVID-19 reveals significant political polarization in public health, impacting vaccine attitudes and infection concerns among Democrats and Republicans.

COVID-19 Revealed Record-High Political Divides in Public Health

Proposed premium increases in the ACA Marketplace for 2026 surge due to rising healthcare costs, specialty drug prices and subsidy uncertainties, according to a recent KFF analysis.

ACA Marketplace Insurers Propose Biggest Premium Hikes Since 2018

Experts criticize the FDA's narrow COVID-19 vaccine approval, warning it limits access and undermines public health amid rising hospitalization rates.

Infectious Disease Expert Warns FDA’s Latest COVID-19 Vaccine Approval Puts Millions at Risk

With healthcare costs climbing, Stuart will lead the nonprofit insurer’s push to keep coverage affordable for 6 million Californians.

Blue Shield of California Names Mike Stuart as New CEO Amid Healthcare Affordability Pressures

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

About Us

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Managed Healthcare Executive - Payer and Population Health Insights

Facebook

LinkedIn

Resource Centers

Eye Care

Spotlight

ASRS 2025

IAS 2025

AMCP Annual

K-Cast: Optimizing Narcolepsy Care

Business

Business Strategy

Chronic Disease

Consumers

Drug Costs

Drug Pipeline

Formulary

Health Management

Health/Disease Strategy

Hospitals & Providers

Industry Analysis

Pharmacy

Politics and Policy

Practice Management

Reimbursement

Technology

1rem

View

Elevating Atopic Dermatitis Care

Future Perspectives on Atopic Dermatitis Treatment

Videos

Lawrence Eichenfield, MD, provides insights on the treatment of atopic dermatitis, highlighting its impact on patients, the evolving therapeutic landscape, and areas of unmet need.

Lawrence Eichenfield, MD, discusses how the treatment landscape for atopic dermatitis has changed in recent years and provides clinical insights on the clinical burden and most burdensome symptoms of the disease.

Treatment Landscape and Clinical Burden of Atopic Dermatitis

Dr Eichenfield provides a comprehensive overview of topical and systemic treatments available for the treatment of patients with atopic dermatitis.

Overview of Treatments for Atopic Dermatitis

An expert dermatologist outlines factors that influence treatment selection for patients with atopic dermatitis and discusses how often patients need systemic therapy, given the available topical therapy options.

Treatment Decisions and the Role of Systemic Therapy in Atopic Dermatitis

An expert on the treatment of atopic dermatitis provides insights on navigating insurance barriers and discusses how managed care organizations can incentivize and support the implementation of evidence-based guidelines and best practices across healthcare settings.

Navigating Insurance Barriers in Atopic Dermatitis

Lawrence Eichenfield, MD, provides clinical insights on evaluating patient response to therapy and managing adverse effects.

Atopic Dermatitis: Evaluating Patient Response to Therapy

Focusing on the future treatment landscape of atopic dermatitis, Dr Eichenfield discusses current unmet needs and highlights standout studies and presentations from the 2024 AAD Annual Meeting.

Lawrence Eichenfield, MD, discusses promising avenues for future research and innovation in the field of atopic dermatitis.

Exciting Developments in Atopic Dermatitis

Future Perspectives on Atopic Dermatitis Treatment

EP: 1.Treatment Landscape and Clinical Burden of Atopic Dermatitis

EP: 2.Overview of Treatments for Atopic Dermatitis

EP: 3.Treatment Decisions and the Role of Systemic Therapy in Atopic Dermatitis

EP: 4.Navigating Insurance Barriers in Atopic Dermatitis

EP: 5.Atopic Dermatitis: Evaluating Patient Response to Therapy

EP: 6.Future Perspectives on Atopic Dermatitis Treatment

EP: 7.Exciting Developments in Atopic Dermatitis

Newsletter